These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30447712)

  • 1. Novel Pharmacotherapy for Hypertrophic Cardiomyopathy.
    Wong TC; Martinez M
    Cardiol Clin; 2019 Feb; 37(1):113-117. PubMed ID: 30447712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Pharmacotherapy in Hypertrophic Cardiomyopathy.
    Andries G; Yandrapalli S; Naidu SS; Panza JA
    Cardiol Rev; 2018; 26(5):239-244. PubMed ID: 29746257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological treatment of hypertrophic cardiomyopathy: current practice and novel perspectives.
    Ammirati E; Contri R; Coppini R; Cecchi F; Frigerio M; Olivotto I
    Eur J Heart Fail; 2016 Sep; 18(9):1106-18. PubMed ID: 27109894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug therapy of hypertrophic cardiomyopathy].
    Hartmann A; Kaltenbach M; Hopf R
    Fortschr Med; 1992 Sep; 110(27):485-8. PubMed ID: 1358773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lifestyle Modification and Medical Management of Hypertrophic Cardiomyopathy.
    Heitner SB; Fischer KL
    Cardiol Clin; 2019 Feb; 37(1):45-54. PubMed ID: 30447715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypertrophic cardiomyopathy (HCM). Surgical versus drug therapy].
    Schulte HD; Gramsch-Zabel H; Schwartzkopff B; Gams E
    Z Kardiol; 1999 Mar; 88(3):163-72. PubMed ID: 10355066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current and emerging pharmacotherapy for the management of hypertrophic cardiomyopathy.
    Rosenzveig A; Garg N; Rao SJ; Kanwal AK; Kanwal A; Aronow WS; Martinez MW
    Expert Opin Pharmacother; 2023; 24(12):1349-1360. PubMed ID: 37272195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of peak provoked left ventricular outflow tract gradients on clinical outcomes in hypertrophic cardiomyopathy.
    Lu DY; Hailesealassie B; Ventoulis I; Liu H; Liang HY; Nowbar A; Pozios I; Canepa M; Cresswell K; Luo HC; Abraham MR; Abraham TP
    Int J Cardiol; 2017 Sep; 243():290-295. PubMed ID: 28747034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aficamten: A Breakthrough Therapy for Symptomatic Obstructive Hypertrophic Cardiomyopathy.
    Sebastian SA; Padda I; Lehr EJ; Johal G
    Am J Cardiovasc Drugs; 2023 Sep; 23(5):519-532. PubMed ID: 37526885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical treatment of hypertrophic cardiomyopathy.
    Sherrid MV; Gunsburg D; Sharma A
    Curr Cardiol Rep; 2000 Mar; 2(2):148-53. PubMed ID: 10980886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Medical treatment for cardiomyopathies].
    Suwa M
    Nihon Rinsho; 2000 Jan; 58(1):59-63. PubMed ID: 10885289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of Mavacamten for Obstructive Hypertrophic Cardiomyopathy and Future Directions.
    Dong T; Alencherry B; Ospina S; Desai MY
    Drug Des Devel Ther; 2023; 17():1097-1106. PubMed ID: 37064432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypertrophic cardiomyopathy: which therapy? Comparison between beta blockers and calcium antagonists on the symptomatology and natural history of the disease].
    Schiavoni G; Favuzzi A; Manzoli U
    Cardiologia; 1985 Apr; 30(4):265-9. PubMed ID: 2870803
    [No Abstract]   [Full Text] [Related]  

  • 14. Exercise echocardiography in hypertrophic cardiomyopathy-upright evaluation needed.
    Cotrim CA; Adame PR; Pereira HH
    Am J Cardiol; 2011 Apr; 107(7):1101-2; author reply 1102. PubMed ID: 21419892
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypertrophic cardiomyopathy: prognosis with medical or surgical therapy.
    Blanchard DG; Ross J
    Clin Cardiol; 1991 Jan; 14(1):11-9. PubMed ID: 1673364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological Management of Hypertrophic Cardiomyopathy: From Bench to Bedside.
    Palandri C; Santini L; Argirò A; Margara F; Doste R; Bueno-Orovio A; Olivotto I; Coppini R
    Drugs; 2022 Jun; 82(8):889-912. PubMed ID: 35696053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical practice. Hypertrophic obstructive cardiomyopathy.
    Nishimura RA; Holmes DR
    N Engl J Med; 2004 Mar; 350(13):1320-7. PubMed ID: 15044643
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypertrophic cardiomyopathy: investigational drugs inhibiting myosin and upcoming agents.
    Hajj Ali A; Mehra N; Desai MY
    Expert Opin Investig Drugs; 2023; 32(9):849-853. PubMed ID: 37787068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic treatment of hypertrophic cardiomyopathy: beta-blockade or calcium blockade or what?
    Goodwin JF
    Cardiovasc Drugs Ther; 1988 Mar; 1(6):665-8. PubMed ID: 2908701
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prognosis of hypertrophic and dilated cardiomyopathy].
    Ikeda H; Imaizumi T
    Nihon Rinsho; 2000 Jan; 58(1):86-92. PubMed ID: 10885294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.